Ameritas Investment Partners’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5K Hold
4,926
﹤0.01% 2295
2025
Q4
$27.8K Hold
4,926
﹤0.01% 2481
2025
Q3
$30.4K Sell
4,926
-1,814
-27% -$10.6K ﹤0.01% 2477
2025
Q2
$32.8K Buy
6,740
+4,534
+206% +$16K ﹤0.01% 2444
2025
Q1
$8.16K Hold
2,206
﹤0.01% 2880
2024
Q4
$8.82K Hold
2,206
﹤0.01% 2932
2024
Q3
$15.4K Hold
2,206
﹤0.01% 2767
2024
Q2
$12.5K Buy
+2,206
New +$19.8K ﹤0.01% 2840
2022
Q2
Sell
-315
Closed -$6K 3215
2022
Q1
$6K Hold
315
﹤0.01% 2937
2021
Q4
$8K Hold
315
﹤0.01% 2966
2021
Q3
$11K Hold
315
﹤0.01% 2918
2021
Q2
$17K Buy
315
+158
+101% +$10.4K ﹤0.01% 2821
2021
Q1
$13K Hold
157
﹤0.01% 2752
2020
Q4
$18K Buy
157
+90
+134% +$5.69K ﹤0.01% 2526
2020
Q3
$2K Hold
67
﹤0.01% 3071
2020
Q2
$3K Hold
67
﹤0.01% 3027
2020
Q1
$2K Hold
67
﹤0.01% 2970
2019
Q4
$4K Hold
67
﹤0.01% 2928
2019
Q3
$10K Hold
67
﹤0.01% 2759
2019
Q2
$6K Hold
67
﹤0.01% 2928
2019
Q1
$9K Hold
67
﹤0.01% 2734
2018
Q4
$27K Hold
67
﹤0.01% 2165
2018
Q3
$47K Buy
67
+16
+31% +$10.1K ﹤0.01% 2025
2018
Q2
$27K Hold
51
﹤0.01% 2340
2018
Q1
$6K Buy
+51
New +$17.2K ﹤0.01% 2834

Other funds holding SLDB

Ameritas Investment Partners's SLDB Position: Q1 2026 in Review

Ameritas Investment Partners held its Solid Biosciences (SLDB) position steady in Q1 2026 at 4,926 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Ameritas Investment Partners first reported a position in SLDB in Q1 2018 and has held it in 25 quarters since. The position peaked at $47K in Q3 2018. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Ameritas Investment Partners held 4,926 shares of Solid Biosciences worth $35.5K as of Q1 2026.
  • Ameritas Investment Partners left its Solid Biosciences share count unchanged in Q1 2026.
  • Solid Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2295 holding.
  • Ameritas Investment Partners first reported a position in Solid Biosciences in Q1 2018 and has held it in 25 quarters since.
  • Ameritas Investment Partners's Solid Biosciences position peaked at $47K in Q3 2018.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.